A Phase 3, randomized, multicenter, multinational, double blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment-naive patients with late onset Pompe disease 27 de Setembro, 2019 By admin